Detalhe da pesquisa
1.
Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study.
BMC Neurol
; 22(1): 64, 2022 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35193507
2.
Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis.
Hum Vaccin Immunother
; 18(1): 2041945, 2022 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35201963
3.
A multicenter retrospective study of clinical features, laboratory characteristics, and outcomes of 166 hospitalized children with coronavirus disease 2019 (COVID-19): A preliminary report from Iranian Network for Research in Viral Diseases (INRVD).
Pediatr Pulmonol
; 57(2): 498-507, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34779156
4.
A Brief Review of Mucormycosis: Report of Five Cases.
Br J Med Med Res
; 2016; 11(9):1-5
Artigo
em Inglês
| IMSEAR | ID: sea-182070